Navigation Links
GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
Date:12/20/2007

ous bleeding was observed in fewer eltrombopag patients (16%) than placebo patients (36%). The most common adverse event (AE) observed in this study was headache, reported in 8% and 11% of patients receiving eltrombopag and placebo respectively. Other common AEs occurring in at least 5% of eltrombopag subjects included nausea, nasopharyngitis, diarrhea and vomiting.

About the Phase II Data(4)

The Phase II study was a multicenter, randomized, double-blind, placebo-controlled trial examining once daily oral dosing of eltrombopag. One hundred and eighteen adults with chronic ITP and platelet counts less than 30,000/microliter who had relapsed or were refractory to at least one ITP treatment were randomized to eltrombopag (30mg, 50mg, or 75 mg), or placebo. The primary endpoint was the proportion of patients with a platelet count greater than or equal to 50,000/microliter after up to six weeks of dosing.

After six weeks of treatment in chronic ITP patients, eltrombopag at daily doses of 30mg, 50mg and 75mg elevated platelet counts to greater than or equal to 50,000/microliter in 28% (8/29), 70% (19/27) and 81% (21/26) of patients respectively compared to 11% (3/27) of patients receiving placebo (pless than0.001). After seven days of treatment 44% and 62% of patients receiving eltrombopag 50mg and 75mg, respectively, achieved a platelet count of greater than or equal to 50,000/microliter. After 15 days, 88% and 81% of patients receiving eltrombopag 50mg and 75mg respectively had responded, with the median platelet counts approaching the normal range (i.e., 150-400,000/microliter). Platelet counts rose to greater than 200,000/microliter in 4% (1/27) of placebo-treated patients and in 14% (4/29), 37% (10/27) and 50% (13/26) of eltrombopag 30mg, 50mg and 75mg-treated patients respectively.

Eltrombopag was generally well tolerated in this study. The most common AE, mild-to-moderate headache, was observed at similar rates in both the eltrombo
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 Companies in ... refine carbon dioxide, selling it to downstream industries in ... for carbon dioxide are food and beverage manufacturers. Food ... as fruits, vegetables or pizzas. The gas is also ... use the compound to carbonate soft drinks, beer and ...
(Date:9/18/2014)... Amy Norton HealthDay Reporter , ... dose of a common antidepressant can quickly alter the way ... The findings, reported online Sept. 18 in Current ... response to widely prescribed antidepressants. Experts said the hope is ... are likely to benefit from a drug -- and which ...
(Date:9/18/2014)... (CHEST) together with the Chinese Thoracic Society (CTS) ... that CHEST World Congress 2016 will be held ... and sleep medicine from around the world are ... spring 2016. , CHEST World Congress 2016 ... training, keynote addresses, presentations by leading health-care experts, ...
(Date:9/18/2014)... City, UT (PRWEB) September 18, 2014 ... America will be recognizing their shared fundraising impact on ... Thursday, Sept. 25. , The first-ever Dance Marathon Day ... than $20 million projected to be raised by college ... community’s CMN Hospital. Donations generated through Dance Marathon campus ...
(Date:9/18/2014)... Baltimore, MD (PRWEB) September 18, 2014 ... Award-winning celebrity and wellness advocate, and Frank Davis, ... Activz Whole-food Nutrition, are pleased to announce ... 150+ ways to make delicious, nutrition-packed meals using ... book is the next step in the ...
Breaking Medicine News(10 mins):Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Montel Williams and Frank Davis Announce New Whole-Food Nutrition Recipe Book, The Simple Scoop, at Natural Products Expo East In Baltimore 2Health News:Montel Williams and Frank Davis Announce New Whole-Food Nutrition Recipe Book, The Simple Scoop, at Natural Products Expo East In Baltimore 3
... Miguel ngel Fullana, researcher at the Universitat Autnoma ... psychologist the Institute of Psychiatric Treatment of Hospital ... College Institute of Psychiatry, London, has carried out ... obsessive-compulsive rituals in childhood with the risk of ...
... March 4 Beginning February 2009, a la mode will ... camisoles for women who have or will undergo mastectomy, lumpectomy ... bra fitters have been trained and certified by Amoena to ... provide a safe, comfortable and supportive environment for women of ...
... Homeopathic Product Offers Clinically Proven Effective Alternative to Controversial ... popular belief, common colds do not decrease ... the availability of a new, naturally safe cold remedy, ... to combat this prevalent virus, which actually strikes more ...
... 4 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... Commercial Development of BioMarin, will present a company update at ... March 11th, 2009 at 2:30 p.m. ET. Interested parties ... via the investor section of the BioMarin website, www.BMRN.com ...
... Inc. (Nasdaq: CLRT ), a premier technology and ... announced that it has rescheduled the release of its financial ... to Wednesday, March 11th in order to complete its year ... of its Form 10-K for the year ended December 31, ...
... Calif., March 4 Scanning the CDC website can ... The CDC concedes that over two million patients will ... many as 100,000 will die as a result. CDC ... morbidity risks and add 9 additional days to a ...
Cached Medicine News:Health News:Obsessive symptoms in childhood can multiply the probabilities of an obsessive compulsive disorder 2Health News:a la mode Bra Fitting Specialty Boutique Now Has Trained Fitters and Products for Women Who Are Post Op Mastectomy or Lumpectomy 2Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 2Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 3Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 4Health News:BioMarin to Present at the Barclays Capital Global Healthcare Conference 2Health News:Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day 2Health News:Mercy Hospital at Folsom Acquires Advanced Germicidal Technology to Battle MRSA, C. diff, Acinetobacter and Other Drug-Resistant Pathogens 2
(Date:9/18/2014)... PHILADELPHIA and LONDON ... new era for biopharmaceutical companies. Competition for innovation, ... necessity to keep up with the fast-changing environment ... also influence clinical trials, and clinical trial costs ... effective patient recruitment. Studies conducted by ...
(Date:9/18/2014)... Sept. 18, 2014  ADM Tronics Unlimited, Inc. ... Ph.D. to its corporate Advisory Board for business ... at the Harvard Medical School and Visiting Professor ... received his Masters degree in Electronics Engineering and ... University of Bologna. After spending a year as ...
(Date:9/18/2014)... , Sept. 18, 2014 MiMedx Group, ... developer, processor and marketer of patent protected regenerative ... announced today that it has entered into a ... MiMedx will provide its dehydrated human amnion/chorion membrane ... non- exclusively on a private label basis. ...
Breaking Medicine Technology:Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3
... SynCardia Systems, Inc. ( www.syncardia.com ), manufacturer of ... CE (Europe) approved Total Artificial Heart, announced record-setting revenue ... part to Certified Centers performing a record number of ... . (Photo: http://photos.prnewswire.com/prnh/20120517/LA08709 ) ...
... 17, 2012  SuccessEHS, a nationally recognized electronic ... software vendor, kicked off its annual Customer ... Birmingham. SuccessEHS selected "Forward Together" as ... commitment to helping its clients successfully navigate the ...
Cached Medicine Technology:SynCardia Posts Record Revenue and Profit in Q1 2012 2SynCardia Posts Record Revenue and Profit in Q1 2012 3SuccessEHS "Forward Together" Customer Conference Begins 2SuccessEHS "Forward Together" Customer Conference Begins 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: